Coherus Biosciences | CHRS - Stock


Coherus Biosciences reported $5.67M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
AbbVie USD 5.13B 78M Jun/2026
Acadia Pharmaceuticals USD 108.67M 77.1M Jun/2026
Akebia Therapeutics USD 13.02M 22K Jun/2026
ALKERMES USD 298.96M 37.75M Jun/2026
Alnylam Pharmaceuticals USD 97.11M 103.04M Jun/2026
Amarin USD 164.07M 19.51M Jun/2026
Amgen USD 6.22B 34M Jun/2026
Baxter International USD 2.26B 57M Jun/2026
Biogen USD 2.38B 435.3M Jun/2026
BioMarin Pharmaceutical USD 1.78B 509.3M Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Coherus Biosciences USD 5.67M 842K Jun/2026
Eli Lilly USD 16.79B 2.26B Jun/2026
Fujifilm JPY 600.8B 678M Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Merck USD 6.21B 272M Jun/2026
Myriad Genetics USD 30.6M 2.7M Jun/2026
Pacira USD 134.57M 15.8M Jun/2026
Perrigo USD 1.06B 56.9M Jun/2026
Pfizer USD 9.94B 722M Jun/2026
PTC Therapeutics USD 91.35M 15.79M Jun/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Sarepta Therapeutics USD 904.27M 96.84M Jun/2026
Teva Pharmaceutical Industries USD 3.18B 3M Mar/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026
Zoetis USD 2.57B 24M Jun/2026